SME Central
Home / Moved to Main Board / Medico Remedies

Medico Remedies: IPO, Share Price and Results Since Listing

Medico Remedies moved from BSE SME to the BSE main board. For Q2 FY2027 it reported revenue of INR 73.97 crore (+40.54% on a year earlier) and a profit after tax of INR 2.38 crore.

Key Facts

Moved to
BSE main board (BSE does not publish the date)
Listed on BSE SME
8 February 2018
Symbol
MEDICO (BSE code 540937)
Latest close
INR 18.49 on 13 November 2026

Results Filed With BSE

Standalone figures, INR crore. Change compares with the same period a year earlier.

PeriodRevenueChangeProfit after taxEPS (INR)Filed
Q2 FY202773.97+40.54%2.380.29after listing9 November 2026
Q1 FY202769.40+81.43%2.520.30after listing13 August 2026
Q4 FY202656.81+37.54%5.860.71after listing21 May 2026
FY2026206.38+36.73%13.121.58after listing21 May 2026
Q3 FY202658.68–2.870.35after listing13 April 2026
Q2 FY202652.64–2.570.31after listing14 November 2025
Q1 FY202638.25–1.820.22after listing8 August 2025
Q4 FY202541.30–4.340.52after listing8 May 2025
FY2025150.94–10.091.22after listing8 May 2025

Promoter Holding

Promoter holding has moved from 61.38% on 30 September 2025 to 61.38% on 30 September 2026 (0 percentage points).

As ofPromotersPublic
30 September 202661.38%38.62%
30 June 202661.38%38.62%
31 March 202661.38%38.62%
31 December 202561.38%38.62%
30 September 202561.38%38.62%

Sources: BSE filings (results XBRL, shareholding pattern, board meetings), BSE daily price files, and IPO records. Prices are not adjusted for bonus issues or splits.